OBJECTIVES: To estimate the prevalence of insulin resistance syndrome (IRS) in a representative sample of youth. To test for the independent contribution of insulin resistance (IR) and adiposity to clustering of metabolic risk factors. To identify the underlying components of IRS. To examine the relationship between adiposity and fasting plasma levels of free fatty acids (FFA). METHODS: In 1999, we conducted a school-based survey of a representative sample of youth aged 9, 13 and 16 y in Quebec, Canada. Age-specific questionnaire data, standardized clinical measurements and a fasting blood sample were available for 2244 subjects. Fasting insulin and HOMA were used as surrogate measures of IR. RESULTS: In all age-sex groups, adiposity indices, blood pressure (BP), plasma glucose and triglycerides (TG) increased significantly with increasing insulin quartiles while HDL cholesterol (HDL-C) decreased. The overall prevalence of IRS defined as hyperinsulinaemia combined with two or more risk factors including overweight, high systolic BP, impaired fasting glucose, high TG and low HDL-C, was 11.5% (95% CI: 10.2-12.9). There were no significant differences in the prevalence of IRS across ages or between sexes. The independent contribution of adiposity to clustering of risk factors was stronger than that of fasting insulin (or HOMA-IR). Factor analysis revealed three factors (BMI/insulin/lipids, BMI/insulin/glucose and diastolic/systolic BP) consistent across ages suggesting that more than one pathophysiologic process underlies IRS. Although elevation of FFA might be in the causal pathway linking obesity to IR, we did not detect any consistent association between measures of fatness and fasting plasma FFA. CONCLUSION: IRS is highly prevalent in youth, even among children as young as age 9 y. Factor analysis identifies three physiologic domains within IRS with a unifying role for markers of IR and adiposity.
OBJECTIVES: To estimate the prevalence of insulin resistance syndrome (IRS) in a representative sample of youth. To test for the independent contribution of insulin resistance (IR) and adiposity to clustering of metabolic risk factors. To identify the underlying components of IRS. To examine the relationship between adiposity and fasting plasma levels of free fatty acids (FFA). METHODS: In 1999, we conducted a school-based survey of a representative sample of youth aged 9, 13 and 16 y in Quebec, Canada. Age-specific questionnaire data, standardized clinical measurements and a fasting blood sample were available for 2244 subjects. Fasting insulin and HOMA were used as surrogate measures of IR. RESULTS: In all age-sex groups, adiposity indices, blood pressure (BP), plasma glucose and triglycerides (TG) increased significantly with increasing insulin quartiles while HDL cholesterol (HDL-C) decreased. The overall prevalence of IRS defined as hyperinsulinaemia combined with two or more risk factors including overweight, high systolic BP, impaired fasting glucose, high TG and low HDL-C, was 11.5% (95% CI: 10.2-12.9). There were no significant differences in the prevalence of IRS across ages or between sexes. The independent contribution of adiposity to clustering of risk factors was stronger than that of fasting insulin (or HOMA-IR). Factor analysis revealed three factors (BMI/insulin/lipids, BMI/insulin/glucose and diastolic/systolic BP) consistent across ages suggesting that more than one pathophysiologic process underlies IRS. Although elevation of FFA might be in the causal pathway linking obesity to IR, we did not detect any consistent association between measures of fatness and fasting plasma FFA. CONCLUSION: IRS is highly prevalent in youth, even among children as young as age 9 y. Factor analysis identifies three physiologic domains within IRS with a unifying role for markers of IR and adiposity.
Authors: Vladimir Vuksan; Valentina Peeva; Alexander Rogovik; Uljana Beljan-Zdravkovic; Mark Stavro; Alexandra Jenkins; Andre G Dias; Sudi Devanesen; John Sievenpiper; Amir Hanna Journal: Can J Cardiol Date: 2010-03 Impact factor: 5.223
Authors: D E Larson-Meyer; B R Newcomer; E Ravussin; J Volaufova; B Bennett; S Chalew; W T Cefalu; M Sothern Journal: Diabetologia Date: 2010-12-23 Impact factor: 10.122
Authors: Katrina D DuBose; Andrew J McKune; Patricia Brophy; Gabriel Geyer; Robert C Hickner Journal: Pediatr Exerc Sci Date: 2015-04-22 Impact factor: 2.333
Authors: Alberta S Kong; Laura Vanderbloemen; Betty Skipper; John Leggott; Emilie Sebesta; Robert Glew; Mark R Burge Journal: J Pediatr Endocrinol Metab Date: 2012 Impact factor: 1.634
Authors: Mindy Dopler Nelson; Lana M Widman; Richard Ted Abresch; Kimber Stanhope; Peter J Havel; Dennis M Styne; Craig M McDonald Journal: J Spinal Cord Med Date: 2007 Impact factor: 1.985
Authors: Chantel Cacciotti; Muhammad Ali; Ute Bartels; Jonathan D Wasserman; Erilda Kapllani; Joerg Krueger; Eric Bouffet; Tal Schechter Journal: Childs Nerv Syst Date: 2020-11-18 Impact factor: 1.475
Authors: Jennifer K Gustafson; Lisa B Yanoff; Benjamin D Easter; Sheila M Brady; Margaret F Keil; Mary D Roberts; Nancy G Sebring; Joan C Han; Susan Z Yanovski; Van S Hubbard; Jack A Yanovski Journal: J Clin Endocrinol Metab Date: 2009-10-16 Impact factor: 5.958
Authors: Joey C Eisenmann; Kelly R Laurson; Katrina D DuBose; Bryan K Smith; Joseph E Donnelly Journal: Diabetol Metab Syndr Date: 2010-01-28 Impact factor: 3.320
Authors: C L Lafortuna; F Adorni; F Agosti; A De Col; R Zennaro; D Caranti; A Sartorio Journal: J Endocrinol Invest Date: 2009-05-05 Impact factor: 4.256